Good evening :)
Switch to
Place Order

Ajanta Pharma Ltd

AJANTPHARM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹16,026 cr, stock is ranked 260
Low RiskStock is 1.51x as volatile as Nifty
1,252.801.07% (+13.30)
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹16,026 cr, stock is ranked 260
Low RiskStock is 1.51x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
22.494.910.51%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.904.360.88%

Forecast & RatingsDetailed Forecast 

73%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Ajanta Pharma Limited is an India-based company, which is primarily involved in development, manufacturing and marketing of specialty pharmaceutical finished dosages. The Company’s marketing network operates in domestic and international markets. The Company produces a comprehensive range of specialty products targeting different therapeutic segments for the treatment of patients, customized to each market it is present in. The branded generics business is spread in India and approximately 30 emerging countries across Africa, South-East Asia, West Asia, and The Commonwealth of Independent States (CIS). It has product portfolio includes complex technology products. The Company has also made substantial investments in its research and development (R&D) facilities.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+2.08+2.68+2.92+3.46+0.39+0.47+0.65+0.71
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Schedule of Analysts/Institutional Investor Meet/Con. Call 
Announced OnNov 25, 2022

Ajanta Pharma Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

Ajanta Pharma Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call | Download

Loss of share certificate 
Announced OnNov 21, 2022

Ajanta Pharma Limited has informed the Exchange about Loss of share certificate | Download

Ajanta Pharma Limited has informed the Exchange about Loss of share certificate | Download

Cash Dividend 
Ex. DateNov 11, 2022

Interim • Div/Share: ₹ 7

See all events